SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech binary events

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (49)6/5/2003 10:39:40 AM
From: nigel bates  Read Replies (2) of 295
 
Thus on one of the subgroups with poorest prognosis, with median survival of only 8 months, there was still 20% survival at 2 years. So even though this data is not an exact analogy by any means, it does indicate that there is a substantial survival tail, which means that we could easily see some placebo patients surviving 2+ years.

5%, surely.

Might another analogy be historic survival rates for metastatic disease prior to the availability of immunotherapy ? Any idea where to find this ?

In any event, we should know something in a couple of months.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext